Cargando…

m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance

Cancer drug resistance has always been a major difficulty in cancer therapy. In the face of drug pressure, resistant cancer cells show complex molecular mechanisms including epigenetic changes to maintain survival. Studies prove that cancer cells exhibit abnormal m6A modification after acquiring dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chen, Guo, Yuying, Guo, Yaxin, Wu, Xiaoke, Si, Chaohua, Xu, Yanxin, Kang, Qiaozhen, Sun, Zhenqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564146/ https://www.ncbi.nlm.nih.gov/pubmed/34745970 http://dx.doi.org/10.3389/fonc.2021.746789

Ejemplares similares

Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
por: Si, Chaohua, et al.
Publicado: (2021)

Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway
por: Chen, Chen, et al.
Publicado: (2023)

RNA N (6)-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
por: Dang, Qin, et al.
Publicado: (2021)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer
por: Sheng, Xianneng, et al.
Publicado: (2021)

Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
por: Liu, Zaoqu, et al.
Publicado: (2022)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
por: Shriwas, Omprakash, et al.
Publicado: (2021)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis
por: Guo, Yaxin, et al.
Publicado: (2021)

N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization
por: Chen, Chen, et al.
Publicado: (2021)

Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy
por: Xu, Yanxin, et al.
Publicado: (2022)

Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues
por: Meng, Qingren, et al.
Publicado: (2023)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Li, Huihuang, et al.
Publicado: (2021)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
por: Zhou, Xuehao, et al.
Publicado: (2022)

Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
por: Chen, Da-Hong, et al.
Publicado: (2021)

m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis
por: Jiang, Xiaohan, et al.
Publicado: (2023)

Transcriptome-wide m(6)A methylome analysis uncovered the changes of m(6)A modification in oral pre-malignant cells compared with normal oral epithelial cells
por: Chen, Xun, et al.
Publicado: (2022)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020)

Variation of Long Non-Coding RNA And mRNA Profiles in Breast Cancer Cells With Influences of Adipocytes
por: Cao, Xin-Hui, et al.
Publicado: (2021)

Crosstalk between RNA m(6)A Modification and Non-coding RNA Contributes to Cancer Growth and Progression
por: Dai, Fengsheng, et al.
Publicado: (2020)

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
por: Liu, Ying, et al.
Publicado: (2022)

m6A Modification: A Double-Edged Sword in Tumor Development
por: Gao, Runnan, et al.
Publicado: (2021)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification
por: Guo, Zhenyun, et al.
Publicado: (2022)

The Role of Cytoskeleton Protein 4.1 in Immunotherapy
por: Si, Chaohua, et al.
Publicado: (2023)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance
por: Ghazimoradi, Mohammad H., et al.
Publicado: (2022)

Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma
por: Li, Yifan, et al.
Publicado: (2023)

Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway
por: Tu, Jianfei, et al.
Publicado: (2021)

Transcriptome Profiling of N7-Methylguanosine Modification of Messenger RNA in Drug-Resistant Acute Myeloid Leukemia
por: Zhang, Bing, et al.
Publicado: (2022)

m(6)A Modifications Play Crucial Roles in Glial Cell Development and Brain Tumorigenesis
por: Wang, Jing, et al.
Publicado: (2021)

The Role of Exosomal microRNA in Cancer Drug Resistance
por: Guo, Qiao-ru, et al.
Publicado: (2020)

The Network of Non-coding RNAs in Cancer Drug Resistance
por: Corrà, Fabio, et al.
Publicado: (2018)

Emerging Roles of m(6)A RNA Methylation Regulators in Gynecological Cancer
por: Huang, Wanjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8mi29a1aquu4ba3msmpdeopsmr